Our engineers has finished development of a new product ELECTROPULSE "RF-50EPI" - RF epicardial ablator. Now a clinical testing is running at Tomsk Research Institute of Cardiology. Application of the ablator includes:

Treatment for medicament-resistant tachycardias and tachyarrhythmias by direct epicardial or endocardial RF energy application on heart conducting pathways.
Treatment of patients with congenital and acquired heart disease correction, coronary bypass and other by RF energy application to heart atria and ventricles.
It is designed for using in hospital and clinics having cardiosurgery departments.